US Stock MarketDetailed Quotes

DVAX Dynavax Technologies

Watchlist
  • 12.770
  • -0.130-1.01%
Close Dec 18 16:00 ET
  • 12.780
  • +0.010+0.08%
Pre 08:51 ET
1.68BMarket Cap85.13P/E (TTM)

About Dynavax Technologies Company

Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.

Company Profile

SymbolDVAX
Company NameDynavax Technologies
Listing DateFeb 19, 2004
Issue Price7.50
Founded1996
CEOMr. Ryan Spencer
MarketNASDAQ
Employees408
Fiscal Year Ends12-31
Address2100 Powell Street,Suite 900
CityEmeryville
ProvinceCalifornia
CountryUnited States of America
Zip Code94608
Phone1-510-848-5100

Company Executives

  • Name
  • Position
  • Salary
  • Ryan Spencer
  • Chief Executive Officer and Director
  • 5.59M
  • Kelly MacDonald
  • Senior Vice President and Chief Financial Officer
  • 1.79M
  • Dr. Robert Janssen, M.D.
  • Chief Medical Officer and Senior Vice President, Clinical Development, Medical and Regulatory Affairs
  • 1.71M
  • Justin Burgess
  • Controller and Chief Accounting Officer
  • --
  • David Novack
  • President and Chief Operating Officer
  • 2.78M
  • John L. Slebir
  • Senior Vice President and General Counsel
  • --
  • Scott D. Myers
  • Chairman of the Board
  • 323.73K
  • Peggy V. Phillips
  • Independent Director
  • 298.73K
  • Elaine D. Sun
  • Independent Director
  • 278.73K
  • Brent MacGregor
  • Independent Director
  • 278.73K
  • Julie M. Eastland
  • Independent Director
  • 293.73K
  • Dr. Peter R. Paradiso, PhD
  • Independent Director
  • 277.73K
  • Dr. Daniel L. Kisner, M.D.
  • Independent Director
  • 290.73K
  • Dr. Francis R. Cano, PhD
  • Independent Director
  • 278.73K
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.